Business/press release/2026-09-23

Novo Nordisk CEO expresses openness to upgrading New York stock listing

Novo Nordisk's CEO has indicated the company's openness to upgrading its New York stock listing. This potential move is aimed at enhancing the pharmaceutical company's profile in the United States, according to an interview the CEO gave to the Financial Times. The company itself is the sole source for this claim.

2 articles from 1 outlet covered this story. The underlying claim is sourced from a press release.

What do all outlets agree on?

1 outlet covered “Novo Nordisk CEO expresses openness to upgrading New York stock listing”. All of them report the following:

  • Novo Nordisk is open to upgrading its New York listing
  • The CEO of Novo Nordisk stated this to the Financial Times
  • The purpose is to boost the company's U.S. profile

Which outlets covered this?

All 2 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.

pragmatist2
Novo Nordisk open to New York listing upgrade, CEO Doustdar tells FTInvesting.com — Stock Market News · financial press
Novo Nordisk open to direct NYSE listing to boost U.S. profile, CEO tells FTInvesting.com — Stock Market News · financial press

What related stories are there?

Get the week in AI in one email

What happened, which outlets reported it, and where their coverage differed. One issue a week.

The first issue hasn’t gone out yet. Subscribe and it’s the one you’ll get.

We’ll send the digest and nothing else. One-click unsubscribe. Privacy.